FDA — authorised 22 October 1996
- Application: NDA020591
- Marketing authorisation holder: ABBVIE
- Local brand name: TARKA
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
🇺🇸 trandolapril/verapamil in United States
FDA authorised trandolapril/verapamil on 22 October 1996
Marketing authorisation
Other Cardiovascular approved in United States
Frequently asked questions
Is trandolapril/verapamil approved in United States?
Yes. FDA authorised it on 22 October 1996.
Who is the marketing authorisation holder for trandolapril/verapamil in United States?
ABBVIE holds the US marketing authorisation.